Abstract
Sphingolipids are essential membrane components, present in all eukaryotic cells, but structurally distinct in mammalian and fungal cells. Therefore, they represent an attractive new target for the development of novel antimycotics. This review will briefly highlight sphingolipid biosynthesis and functions in the yeast Saccharomyces cerevisiae. In addition, naturally occurring antifungal compounds that interact with fungal-specific sphingolipids, resulting in fungal growth arrest, will be discussed regarding their mode of action, and therapeutic value. These compounds include plant and insect defensins, syringomycin E and antifungal antibodies to sphingolipids.
Keywords: mode of action, sphingolipid, defensin, syringomycin E, anti-GlcCer antibody, antifungal
Current Drug Targets
Title: Fungal Sphingolipids as Targets for the Development of Selective Antifungal Therapeutics
Volume: 6 Issue: 8
Author(s): K. Thevissen, I.E. J.A. Francois, A. M. Aerts and B. P.A. Cammue
Affiliation:
Keywords: mode of action, sphingolipid, defensin, syringomycin E, anti-GlcCer antibody, antifungal
Abstract: Sphingolipids are essential membrane components, present in all eukaryotic cells, but structurally distinct in mammalian and fungal cells. Therefore, they represent an attractive new target for the development of novel antimycotics. This review will briefly highlight sphingolipid biosynthesis and functions in the yeast Saccharomyces cerevisiae. In addition, naturally occurring antifungal compounds that interact with fungal-specific sphingolipids, resulting in fungal growth arrest, will be discussed regarding their mode of action, and therapeutic value. These compounds include plant and insect defensins, syringomycin E and antifungal antibodies to sphingolipids.
Export Options
About this article
Cite this article as:
Thevissen K., Francois J.A. I.E., Aerts M. A. and Cammue P.A. B., Fungal Sphingolipids as Targets for the Development of Selective Antifungal Therapeutics, Current Drug Targets 2005; 6 (8) . https://dx.doi.org/10.2174/138945005774912771
DOI https://dx.doi.org/10.2174/138945005774912771 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
IL-37 As a Potential Biotherapeutics of Inflammatory Diseases
Current Drug Targets <i>Origanum vulgare</i> L.: <i>In vitro</i> Assessment of Cytotoxicity, Molecular Docking Studies, Antioxidant and Anti-inflammatory Activity in LPS Stimulated RAW 264.7 Cells
Medicinal Chemistry Drug-Induced Liver Injury: Mechanisms, Types and Biomarkers
Current Medicinal Chemistry The Roles of ID, IA and IK in the Electrophysiological Functions of Small-Diameter Rat Trigeminal Ganglion Neurons
Current Molecular Pharmacology The Therapeutic Potential of Toll-Like Receptor 7 Stimulation in Asthma
Inflammation & Allergy - Drug Targets (Discontinued) TRPV1: On the Road to Pain Relief
Current Molecular Pharmacology A Review of Clinical Trials of Belimumab in the Management of Systemic Lupus Erythematosus
Current Pharmaceutical Design New Therapeutic Strategies for Cancer and Neurodegeneration Emerging from Yeast Cell-based Systems
Current Pharmaceutical Design Macrophage Derived Cystatin B/Cathepsin B in HIV Replication and Neuropathogenesis
Current HIV Research Molecular Genetics of Polycystic Ovary Syndrome: An Update
Current Molecular Medicine Clozapine Safety, 40 Years Later
Current Drug Safety γ-Hydroxybutenolide Containing Marine Natural Products and Their Synthesis: A Review
Current Organic Chemistry Oxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes Mellitus
Current Neurovascular Research Synthesis and Evaluation of Some Novel Pregnane Derivatives as Anti-Hyperlipidemic and Anti-Oxidant Agents
Letters in Organic Chemistry In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases
Infectious Disorders - Drug Targets Cinnamic Acid Derivatives Induce Cell Cycle Arrest in Carcinoma Cell Lines
Medicinal Chemistry The Significance of Chirality in Drug Design and Development
Current Topics in Medicinal Chemistry The Management of Metastatic Bone Disease with the Combination of Bisphosphonates and Radiotherapy: From Theory to Clinical Practice
Anti-Cancer Agents in Medicinal Chemistry Preconditioning and Shear Stress in the Microcirculation in Ischemia-Reperfusion Injury
Current Cardiology Reviews Bacterial Lipopolysaccharides in Plant and Mammalian Innate Immunity
Protein & Peptide Letters